{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:42:21Z","timestamp":1747183341116,"version":"3.40.5"},"reference-count":8,"publisher":"Wiley","issue":"11-12","license":[{"start":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100002380","name":"Hanyang University","doi-asserted-by":"publisher","award":["HY\u2010202300000001159"],"award-info":[{"award-number":["HY\u2010202300000001159"]}],"id":[{"id":"10.13039\/501100002380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>LINKED CONTENT<\/jats:title><jats:p>This article is linked to Kim et al papers. To view these articles, visit<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.1111\/apt.17726\">https:\/\/doi.org\/10.1111\/apt.17726<\/jats:ext-link>and<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.1111\/apt.17757\">https:\/\/doi.org\/10.1111\/apt.17757<\/jats:ext-link><\/jats:p>","DOI":"10.1111\/apt.17780","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T19:12:49Z","timestamp":1700680369000},"page":"1240-1241","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Liver hypercortisolism as a potential target for MASH treatment\u2014Authors' reply"],"prefix":"10.1111","volume":"58","author":[{"given":"Yun","family":"Kim","sequence":"first","affiliation":[{"name":"College of Pharmacy, Daegu Catholic University Gyeongsan Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4953-759X","authenticated-orcid":false,"given":"Inyoung","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics Hanyang University Seoul Hospital Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3862-9491","authenticated-orcid":false,"given":"Sang W.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics Hanyang University Seoul Hospital Seoul Republic of Korea"},{"name":"Department of Pharmacology Hanyang University, College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/apt.17757","article-title":"Editorial: liver hypercortisolism as a potential target for MASH treatment","volume":"58","author":"Harrison SA","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.015"},{"issue":"7","key":"e_1_2_6_4_1","first-page":"371","article-title":"Update on clinical trials for nonalcoholic steatohepatitis","volume":"19","author":"Nathani RR","year":"2023","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2015.07.020"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419\u2010022\u201005452\u2010x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27368"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.17726","article-title":"First in human randomised trial of J2H\u20101702: a novel 11\u03b2\u2010hydroxysteroid dehydrogenase type 1 inhibitor for non\u2010alcoholic steatohepatitis treatment","volume":"58","author":"Kim Y","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_6_9_1","unstructured":"CRIS.A multi\u2010center randomized double\u2010blind placebo\u2010controlled phase IIa clinical trial to evaluate the safety and explore the efficacy of J2H\u20101702 for non\u2010alcoholic steatohepatitis. Accessed October 8 2023.https:\/\/cris.nih.go.kr\/cris\/search\/detailSearch.do?search_lang=E&focus=reset_12&search_page=L&pageSize=10&page=undefined&seq=24226&status=5&seq_group=22995"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.17780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T06:55:51Z","timestamp":1703573751000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.17780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":8,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1111\/apt.17780"],"URL":"https:\/\/doi.org\/10.1111\/apt.17780","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"type":"print","value":"0269-2813"},{"type":"electronic","value":"1365-2036"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"2023-11-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}